Compare
Greenland Mines Ltd vs Dyadic International Inc vs Calidi Biotherapeutics, Inc. vs Scinai Immunotherapeutics Ltd.
| Latest fiscal year | Greenland Mines Ltd GRML | Dyadic International Inc DYAI | Calidi Biotherapeutics, Inc. CLDI | Scinai Immunotherapeutics Ltd. SCNI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $3.09M | n/a | $1.31M |
| Revenue growth (YoY) | n/a | -11.6% | n/a | +99.2% |
| Gross margin | n/a | 24.9% (computed) | n/a | -202.3% |
| Operating margin | n/a | -232.8% | n/a | -575.3% |
| Net margin | n/a | -238.3% | n/a | -633.6% |
| Net income | -$10.55M | -$7.36M | -$19.91M | -$8.31M |
| EPS (Diluted) | -$0.22 | -$0.23 | -$5.95 | n/a |
| Operating cash flow | -$5.89M | -$5.70M | -$21.29M | -$6.03M |
| Free cash flow | n/a | n/a | n/a | -$6.05M |
| Cash & equivalents | $7.18M | $4.62M | n/a | $1.66M |
| Total assets | $9.59M | $9.95M | $8.86M | $11.63M |
| Total liabilities | $129.8K | $8.71M | $5.10M | n/a |
| Shareholders' equity | $9.46M | $1.23M | $3.76M | $8.10M |
| Return on year-end equity | -111.5% | -597.6% | -529.6% | -102.5% |
| Shares outstanding | 72.54M | 36.19M | 7.22M | 13.87B |
Revenue, most recent five fiscal years
| Fiscal year | Greenland Mines Ltd | Dyadic International Inc | Calidi Biotherapeutics, Inc. | Scinai Immunotherapeutics Ltd. |
|---|---|---|---|---|
| Latest | n/a | $3.09M Ended 2025-12-31 | $45.0K Ended 2022-12-31 | $1.31M Ended 2025-12-31 |
| 1 year earlier | n/a | $3.50M Ended 2024-12-31 | n/a | $658.0K Ended 2024-12-31 |
| 2 years earlier | n/a | $2.90M Ended 2023-12-31 | n/a | n/a |
| 3 years earlier | n/a | $2.93M Ended 2022-12-31 | n/a | n/a |
| 4 years earlier | n/a | $2.40M Ended 2021-12-31 | n/a | n/a |